AIarXiv
Ranked by formulaVerdict: NotableMeta-CLIP: Metadata-Conditioned Contrastive Learning for Zero-Shot Disease Inference
Medical vision--language pretraining learns transferable representations from paired images and radiology reports, yet differences in scanners and acquisition protocols can impair transfer.
Key numbers
- 95% paired bootstrap confidence interval
Caveats
- Preprint; not yet peer reviewed.
VerdictWorth a reader's time today.
Abstract
Medical vision--language pretraining learns transferable representations from paired images and radiology reports, yet differences in scanners and acquisition protocols can impair transfer. Existing approaches primarily enrich clinical semantics, leaving structured acquisition information in DICOM headers underused. We introduce Meta-CLIP, a metadata-conditioned contrastive framework that uses acquisition similarity to reweight cross-modal negatives during pretraining. A kernel over numerical and categorical DICOM fields defines a bounded pairwise margin. This margin increases the contribution of acquisition-similar negatives, emphasizing distinctions among studies that share imaging conditions. The kernel remains fixed during image--text optimization, and inference follows the standard dual-encoder architecture without requiring metadata. We evaluate Meta-CLIP on chest radiography and volumetric chest CT through zero-shot classification, appearance perturbations, grounding, and representation analyses. On CT-RATE, Meta-CLIP improves macro-AUROC over CT-CLIP by 1.41 points, with a 95% paired bootstrap confidence interval of 0.96--1.85 points. It also achieves the highest macro-AUROC on four of five CXR benchmarks. An exploratory BrgSA evaluation extends the analysis to another CT backbone. These findings support acquisition metadata as a practical training-time prior for medical vision--language learning. Code will be made publicly available upon publication.
The editor's rubric
- Leverage4 / 5
- A general-purpose tool used across several fields (Adam, ResNet, LoRA, next-generation sequencing).
- Magnitude3 / 5
- Large gain: roughly 2x, or a clear new state of the art on a hard, unsaturated problem.
- Evidence3 / 5
- Solid: multiple benchmarks or cohorts, ablations, fair baselines, released code or data.
- Novelty3 / 5
- A genuinely new approach to an open problem.
- Trajectory3 / 5
- A clear path to scale.
- Stakes2 / 5
- Benefits a professional community (practitioners, clinicians, engineers).
Editor’s rationale
Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: method (we propose); breadth (many tasks, zero/few-shot); gains (relative gain); novelty (alternative to status quo); verification (confidence interval, multiple benchmarks, code released). Red flags: weak evidence (preliminary).
How the score was computed
Desks place stronger verdicts first, then use this score to order work within the same verdict.
- Merit
- 6.3 / 10
- Adjusted merit
- 5.0 / 10
- Attention
- 0%
- Freshness
- 50%